ZTSZoetis Inc.vs its industry peers
A metric-by-metric comparison of Zoetis Inc. against Health Care Select Sector SPDR Fund holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZTSEsta | $30.3B#16 | 12.0x#1 | 9.6x#11 | 3.2x#5 | 2.3%#13 | 7.5%#8 | 37.8%#2 | 84.9%#1 | 25.4%#3 | — | -48.3%#15 | 2.9%#3 |
| LLY | $1.07T#1 | 38.2x#12 | 31.6x#15 | 16.4x#16 | 44.7%#1 | 94.9%#4 | 40.2%#1 | 60.9%#4 | 26.3%#2 | — | 52.7%#3 | 0.5%#13 |
| JNJ | $643.7B#2 | 31.0x#8 | 7.6x#9 | 6.8x#12 | 6.0%#8 | 90.6%#5 | 22.9%#9 | 31.5%#8 | 16.1%#8 | 6#2 | 53.4%#2 | 1.9%#11 |
| ABBV | $464.7B#3 | 74.3x#14 | — | 7.6x#13 | 8.6%#6 | -1.2%#11 | 24.6%#8 | — | 18.6%#7 | — | 23.8%#10 | 2.5%#6 |
| UNH | $337.4B#5 | 24.2x#4 | 10.2x#12 | 0.8x#2 | 11.8%#3 | -16.3%#14 | 4.2%#15 | 36.5%#6 | 21.3%#6 | — | 10.5%#13 | 2.3%#7 |
| MRK | $354.6B#4 | 115.0x#15 | 8.5x#10 | 5.5x#8 | 1.3%#14 | 6.6%#9 | 34.2%#4 | 43.5%#5 | 21.6%#5 | — | 81.4%#1 | 2.3%#9 |
| AMGN | $203.1B#7 | 23.3x#3 | 17.4x#14 | 5.5x#9 | 10.0%#4 | 88.5%#6 | 24.7%#7 | 66.0%#3 | 15.1%#9 | — | 40.3%#5 | 2.5%#5 |
| TMO | $237.2B#6 | 34.5x#9 | 4.5x#5 | 5.3x#7 | 3.9%#10 | 6.0%#10 | 17.4%#13 | 12.8%#11 | 10.1%#11 | — | 35.5%#6 | 0.3%#14 |
| ABT | $177.7B#9 | 28.6x#6 | 3.4x#4 | 4.0x#6 | 5.7%#9 | -51.3%#15 | 18.2%#12 | 12.5%#12 | 8.3%#12 | — | — | 2.3%#8 |
| GILD | $181.4B#8 | — | 15.3x#13 | 6.2x#11 | 2.4%#12 | 1672.9%#1 | 34.0%#5 | 71.9%#2 | 26.7%#1 | — | 32.9%#7 | 2.2%#10 |
| ISRG | $133.3B#12 | 43.3x#13 | 7.3x#8 | 13.2x#15 | 20.5%#2 | 23.0%#7 | 29.3%#6 | 15.7%#10 | — | — | -13.1%#14 | — |
| PFE | $157.0B#10 | 36.2x#10 | 1.8x#2 | 2.5x#3 | -1.6%#16 | -3.2%#12 | 16.3%#14 | 9.1%#13 | 6.9%#13 | — | 22.0%#11 | 6.2%#1 |
| CVS | $120.8B#15 | 24.9x#5 | 1.5x#1 | 0.3x#1 | 7.8%#7 | -61.7%#16 | 1.2%#16 | 2.2%#15 | 2.9%#15 | 6#2 | 32.2%#8 | 2.8%#4 |
| VRTX | $130.4B#13 | 30.0x#7 | 6.4x#7 | 10.9x#14 | 8.9%#5 | 838.1%#2 | 34.8%#3 | 19.5%#9 | 25.0%#4 | — | 31.0%#9 | — |
| DHR | $147.1B#11 | 37.2x#11 | 2.8x#3 | 6.0x#10 | 2.9%#11 | -7.3%#13 | 19.1%#11 | 6.9%#14 | 5.4%#14 | 5#4 | 11.6%#12 | 0.6%#12 |
| BMY | $130.2B#14 | 14.0x#2 | 5.8x#6 | 2.7x#4 | -0.2%#15 | 178.8%#3 | 21.8%#10 | 31.6%#7 | 14.0%#10 | 7#1 | 42.8%#4 | 3.9%#2 |
Peer set: top holdings of XLV (Health Care Select Sector SPDR Fund), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice